Morphic Holding, Inc. ( MORF) - Key Metrics
Stock symbol MORF is outdated, potentially delisted? Maybe it is available on other exchange?
MORF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | ? | -$1.15 | -$0.64 | -$0.65 |
| 2024Q1 | ? | -$0.91 | -$0.93 | -$0.94 |
| 2023Q4 | -$1.21 | -$0.82 | -$0.57 | -$0.58 |
| 2023Q3 | ? | -$0.73 | -$0.59 | -$0.60 |
| 2023Q2 | $1.42 | -$0.92 | -$0.54 | -$0.55 |
MORF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -7.08 |
| 2024Q1 | ? | -9.08 |
| 2023Q4 | ? | -8.82 |
| 2023Q3 | ? | -7.84 |
| 2023Q2 | ? | -15.57 |
MORF
Price: $56.99
52 week price:
Earnings Per Share: -3.83 USD
P/E Ratio: -10.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 148800
Market Capitalization: 2.9 billion